ID   HPSI0714i-gibe_2
AC   CVCL_AG77
SY   WTSIi159-A
DR   BioSamples; SAMEA3336930
DR   EBiSC; WTSIi159-A
DR   ECACC; 66540313
DR   ECACC; 77650278
DR   HipSci; HPSI0714i-gibe_2
DR   hPSCreg; WTSIi159-A
DR   SKIP; SKIP002811
DR   Wikidata; Q54891299
RX   PubMed=30784590;
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Deep exome analysis.
CC   Omics: Deep proteome analysis.
CC   Omics: DNA methylation analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Discontinued: ECACC; 66540313; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 15
//
RX   PubMed=30784590; DOI=10.1016/j.celrep.2019.01.094;
RA   Vigilante A., Laddach A., Moens N., Meleckyte R., Leha A.,
RA   Ghahramani A., Culley O.J., Kathuria A., Hurling C., Vickers A.,
RA   Wiseman E., Tewary M., Zandstra P.W., Durbin R., Fraternali F.,
RA   Stegle O., Birney E., Luscombe N.M., Danovi D., Watt F.M.;
RT   "Identifying extrinsic versus intrinsic drivers of variation in cell
RT   behavior in human iPSC lines from healthy donors.";
RL   Cell Rep. 26:2078-2087.e3(2019).
//